Merck

Merck & Co., Inc., a global biopharmaceutical company, invests in emerging healthcare technology companies through its venture capital arm, Merck Global Health Innovation Fund (GHI). Established in 2010, GHI focuses on digital health, data science, and other innovative solutions that can enhance patient outcomes and transform healthcare. With over $500 million under management, GHI provides growth capital to startups and growth-stage companies worldwide, leveraging Merck's extensive R&D and global resources to accelerate their development. GHI's portfolio spans digital health, diagnostics, precision medicine, and other emerging technologies, with a vision that data will be the currency driving healthcare's future.